Search Results - "Ye, Caiying"
-
1
Carboxyamidotriazole alleviates pannus formation and cartilage erosion in rats with adjuvant arthritis
Published in Heliyon (01-09-2023)“…Carboxyamidotriazole (CAI) was initially considered a non-cytotoxic anticancer agent. However, recently, pronounced anti-inflammatory properties of CAI have…”
Get full text
Journal Article -
2
Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy
Published in Journal for immunotherapy of cancer (11-09-2019)“…BackgroundCancer immunotherapy has generated significant excitement, mainly as a result of the development of immune checkpoint inhibitors. The blockade of…”
Get full text
Journal Article -
3
MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway
Published in Anti-cancer agents in medicinal chemistry (01-01-2016)“…Accumulated evidences suggested that microRNAs (miRs) play an important role in non-small cell lung cancer (NSCLC). However, how miRs perform their functions…”
Get more information
Journal Article -
4
Inhibition of pro-inflammatory cytokines in tumour associated macrophages is a potential anti-cancer mechanism of carboxyamidotriazole
Published in European journal of cancer (1990) (01-05-2012)“…Abstract Carboxyamidotriazole (CAI) has not only direct anti-cancer activities, but also anti-inflammation effects in a variety of inflammatory animal models…”
Get full text
Journal Article -
5
Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumorostatic agent
Published in The Journal of pharmacology and experimental therapeutics (01-04-2008)“…Carboxyamidotriazole (CAI) is a calcium influx inhibitor that is undergoing clinical trials for the treatment of various human cancers following the…”
Get more information
Journal Article -
6
Regulator of G protein signaling proteins differentially modulate signaling of μ and δ opioid receptors
Published in European journal of pharmacology (22-06-2007)“…Effects of regulator of G protein signaling (RGS) proteins on μ and δ opioid receptors were investigated in HEK293 cells. Co-expression of RGS1, RGS2, RGS4,…”
Get full text
Journal Article -
7
AIM2 and NLRC4-driven inflammasome activation in adult-onset Still’s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole
Published in Clinical rheumatology (01-06-2023)“…Objectives This study aimed to explore the changes of four major inflammasomes in adult-onset Still’s disease (AOSD) and preliminarily evaluate the therapeutic…”
Get full text
Journal Article -
8
NALP1 inflammasome activation in adjuvant arthritis rats is a novel therapeutic target of carboxyamidotrizole in the treatment of rheumatoid arthritis
Published in The Journal of immunology (1950) (01-05-2016)“…Abstract BACKGROUND AND PURPOSE Pro-inflammatory cytokines play an important role in rheumatoid arthritis (RA) and their production is mainly regulated by…”
Get full text
Journal Article -
9
Discovery of novel triazole compounds as selective IL-1β releasement inhibitors
Published in Bioorganic & medicinal chemistry letters (01-12-2021)“…[Display omitted] Inflammation and immunity are closely related to the occurrence and development of a variety of immune diseases. Although IL-1β has been…”
Get full text
Journal Article -
10
Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition
Published in Cancer letters (28-01-2016)“…Highlights • CAI is confirmed to inhibit OXPHOS in cancer cells for the first time. • Anti-cancer effect of CAI is greatly improved by being combined with…”
Get full text
Journal Article -
11
Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation
Published in International immunopharmacology (01-04-2017)“…Excess proinflammatory cytokines owing to the activation of NF-κB and NLRP3 inflammasome play the key role in inflammatory bowel disease (IBD). Previously, we…”
Get full text
Journal Article -
12
Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis
Published in The Journal of pharmacology and experimental therapeutics (01-08-2017)“…Lung cancer is currently the leading cause of cancer-related deaths worldwide. In this study, we investigated the combination of carboxyamidotriazole (CAI) and…”
Get more information
Journal Article -
13
Improved Free Musculocutaneous Flap Survival with Induction of Heat Shock Protein
Published in Plastic and reconstructive surgery (1963) (01-03-1998)“…The cellular response to a wide variety of stresses results in the synthesis of a family of stress response proteins termed heat shock proteins. Recent studies…”
Get full text
Journal Article -
14
Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis
Published in British journal of pharmacology (01-07-2015)“…Background and Purpose Pro‐inflammatory cytokines are important in rheumatoid arthritis (RA) and their production is mainly regulated by NF‐κB and…”
Get full text
Journal Article -
15
Carboxyamidotriazole: A novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases
Published in European journal of pharmacology (05-01-2015)“…Carboxyamidotriazole (CAI) is a non-cytotoxic anti-tumor drug, which also shows considerable anti-inflammatory effects in a variety of animal models of…”
Get full text
Journal Article -
16
Carboxyamidotriazole exerts anti‑inflammatory activity in lipopolysaccharide‑induced RAW264.7 macrophages by inhibiting NF‑κB and MAPKs pathways
Published in Experimental and therapeutic medicine (01-08-2020)“…Carboxyamidotriazole (CAI), originally developed as a non-cytotoxic anti-cancer drug, was shown to have anti-inflammatory activity according to recent studies…”
Get full text
Journal Article -
17
Improvement of mitochondrial function mediated the neuroprotective effect of 5-(4-hydroxy-3-dimethoxybenzylidene)-2-thioxo-4-thiazolidinone in rats with cerebral ischemia-reperfusion injuries
Published in Oncotarget (22-09-2017)“…Deficits in mitochondrial function is a critical inducement in the major pathways that drive neuronal cell death in ischemic process particularly. Drugs target…”
Get full text
Journal Article -
18
Carboxyamidotriazole exerts anti-inflammatory activity in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-[kappa]B and MAPKs pathways
Published in Experimental and therapeutic medicine (01-08-2020)“…Carboxyamidotriazole (CAI), originally developed as a non-cytotoxic anti-cancer drug, was shown to have anti-inflammatory activity according to recent studies…”
Get full text
Journal Article -
19
Activation of NALP 1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis
Published in British journal of pharmacology (01-07-2015)“…Background and Purpose Pro‐inflammatory cytokines are important in rheumatoid arthritis ( RA ) and their production is mainly regulated by NF ‐ κB and…”
Get full text
Journal Article -
20
Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis
Published in The Journal of pharmacology and experimental therapeutics (01-08-2012)“…Carboxyamidotrizole (CAI) has been reported to suppress the production of tumor necrosis factor-α (TNF-α) and interleukin (IL)-1β and be effective in rats with…”
Get more information
Journal Article